Core Laboratories NV (CLB) Tops Q3 EPS by 2c; Issues Light Q4 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $10.40 -0.86%
Financial Fact:
Other (income), net: -288K
Today's EPS Names:
PFBX, GOVB, VABK, More
Financial Fact:
Other (income), net: -288K
Today's EPS Names:
PFBX, GOVB, VABK, More
Join SI Premium – FREE
Core Laboratories NV (NYSE: CLB) reported Q3 EPS of $1.53, $0.02 better than the analyst estimate of $1.51. Revenue for the quarter came in at $276.14 million versus the consensus estimate of $284.3 million.
Core Laboratories NV sees Q4 2014 EPS of $1.53-$1.56, versus the consensus of $1.6. Core Laboratories NV sees Q4 2014 revenue of $275-280 million, versus the consensus of $292.8 million.
For earnings history and earnings-related data on Core Laboratories NV (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SPS Commerce (SPSC) Tops Q3 EPS by 16c; Offers Guidance
- Veralto Corporation (VLTO) Tops Q3 EPS by 23c; raises guidance
- Starz Entertainment Corp. (STRZ) Reports Q3 Loss of $2.02
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
